An open call for nano-based therapy to address COVID-19 and oncological clinical conditions
Int J Surg
.
2024 Apr 1;110(4):2430-2432.
doi: 10.1097/JS9.0000000000000071.
Authors
Rasmita Dash
1
,
Rudra N Sahoo
2
,
Gurudutta Pattnaik
2
,
Ashish K Sarangi
3
,
Venkataramana Kandi
4
,
Snehasish Mishra
5
,
Sarika Verma
6
7
,
Ranjan K Mohapatra
8
Affiliations
1
School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University).
2
School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneswar, Odisha.
3
Department of Chemistry, School of Applied Sciences, Centurion University of Technology and Management, Balangir, Odisha.
4
Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana.
5
School of Biotechnology, Campus-11, KIIT (Deemed-to-be-University), Bhubaneswar, Odisha.
6
Academy of Council Scientific and Industrial Research - Advanced Materials and Processes Research Institute (AMPRI).
7
Council of Scientific and Industrial Research - Advanced Materials and Processes Research Institute, Bhopal, Madhya Pradesh.
8
Department of Chemistry, Government College of Engineering, Keonjhar, Odisha, India.
PMID:
36974677
PMCID:
PMC11020012
DOI:
10.1097/JS9.0000000000000071
No abstract available
Publication types
Editorial
Letter
MeSH terms
COVID-19* / therapy
Humans
Neoplasms* / therapy
SARS-CoV-2